RP-HPLC method development and validation for the estimation of irinotecan in bulk form and marketed pharmaceutical dosage form
Abstract
A simple, Accurate, precise method was developed for the estimation of the Irinotecan in API and Marketed Pharmaceutical Dosage forms. Chromatogram was run through Symmetry ODS (C18) RP Column, 250 mm x 4.6 mm, 5µm. Mobile phase containing Acetonitrile, Methanol and 0.1% Ortho Phosphoric Acid taken in the ratio 60:30:10% v/v/v was pumped through column at a flow rate of 1.0 ml/min. Buffer used in this method was 0.1% OPA. Temperature was maintained at Ambient. Optimized wavelength selected was 235 nm. Retention time of Irinotecan was found to be 2.570min. %RSD of the Method Precision for Irinotecan were and found to be 0.768. %Recovery was obtained as 100.59% for Irinotecan. LOD, LOQ values obtained from regression equations of Irinotecan were 0.08 and 0.24 respectively. Regression equation of Irinotecan is y = 19423x + 5444.4 of Irinotecan. Retention time was decreased and run time was decreased, so the method developed was simple and economical that can be adopted in regular Quality control test in Industries.
How to Cite This Article
CA Sri Ranjani, Asha Deepti C, V Sravan Kumar, Mallebanthula Shailaja, Bhukya Kalyani, Nemmadi Naveen, Palthya Vinod (2023). RP-HPLC method development and validation for the estimation of irinotecan in bulk form and marketed pharmaceutical dosage form . International Journal of Multidisciplinary Research and Growth Evaluation (IJMRGE), 4(3), 419-425. DOI: https://doi.org/10.54660/.IJMRGE.2023.4.3.419-425